In the HU group, the relevant indicators were all rescued with the administration of κ-OR agonist U50488H, implying that κ-OR agonist has the capability in improving myocardial injury in HF rats and enhancing the left ventricular systolic and diastolic function. The gene discussed is OPRK1; the disease is hydrops fetalis.